Stock Scorer

Healthy Extracts Inc. (HYEX)

Healthy Extracts Inc. reported revenue of 2.1M USD for the quarter ending 30 June 2026, up 113.4% from 968.7K a year earlier.

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than filled in. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD. The same series drawn ›

As last reported

The newest period the filing supports for each figure, in USD.
FigurePeriodAmountYear on year
Revenue Q2 '26 · ending 30 June 2026 2.1M +113.4%
Gross Profit Q2 '26 · ending 30 June 2026 1.5M +145.0%
Net Income Q2 '26 · ending 30 June 2026 -129.4K -292.8%
Cost of Revenue Q2 '26 · ending 30 June 2026 614.8K +63.6%
Operating Cash Flow Q2 '26 · ending 30 June 2026 306K +409.8%
Free Cash Flow Q2 '24 · ending 30 June 2024 169.1K —
EPS Q3 '21 · ending 30 September 2021 0.02 —

Revenue and profit by financial year

As filed, in USD. A year the filing does not support is not listed.
YearEnding RevenueOperating IncomeNet IncomeFree Cash Flow
20252025-12-31 4.5M—-881.1K—
20242024-12-31 3.1M—-840.7K—
20232023-12-31 2.5M—-2.5M-415.7K
20222022-12-31 2.3M—-983.1K-398.6K
20212021-12-31 1.7M—-2M-901.3K
20202020-12-31 1.3M—-2.6M—
20192019-12-31 748.4K—632.8K-1.8M
20182018-12-31 67.1K-3.3M-3.3M—
20172017-12-31 7.6K-3.6M-3.6M—
20162016-12-31 162.8K-825.8K-3.4M—

Every period

Revenue Quarterly

PeriodEndingRevenue
Q2 '262026-06-302.1M
Q1 '262026-03-311.6M
Q4 '252025-12-311.7M
Q3 '252025-09-30918K
Q2 '252025-06-30968.7K
Q1 '252025-03-31931.3K
Q4 '242024-12-31771.2K
Q3 '242024-09-30744.9K
Q2 '242024-06-30908.4K
Q1 '242024-03-31688.8K
Q4 '232023-12-31668.9K
Q3 '232023-09-30613.5K
Q2 '232023-06-30588.5K
Q1 '232023-03-31614.9K
Q4 '222022-12-31818.6K
Q3 '222022-09-30499.7K
Q2 '222022-06-30469.8K
Q1 '222022-03-31551.7K
Q4 '212021-12-31773.5K
Q3 '212021-09-30448K

Gross Profit Quarterly

PeriodEndingGross Profit
Q2 '262026-06-301.5M
Q1 '262026-03-31988.7K
Q4 '252025-12-31957.4K
Q3 '252025-09-30447.2K
Q2 '252025-06-30592.8K
Q1 '252025-03-31425K
Q4 '242024-12-31414.4K
Q3 '242024-09-30602.5K
Q2 '242024-06-30486.1K
Q1 '242024-03-31408.4K
Q4 '232023-12-31565.7K
Q3 '232023-09-30493.2K
Q2 '232023-06-30285.1K
Q1 '232023-03-31277.8K
Q4 '222022-12-31341.5K
Q3 '222022-09-30431.1K
Q2 '222022-06-30274.3K
Q1 '222022-03-31324.7K
Q4 '212021-12-3148.3K
Q3 '212021-09-30307.6K

Net Income Quarterly

PeriodEndingNet Income
Q2 '262026-06-30-129.4K
Q1 '262026-03-31-200.6K
Q4 '252025-12-31-154K
Q3 '252025-09-30-395.4K
Q2 '252025-06-3067.1K
Q1 '252025-03-31-398.9K
Q4 '242024-12-31-446.9K
Q3 '242024-09-30354.5K
Q2 '242024-06-30113.5K
Q1 '242024-03-31-861.3K
Q4 '232023-12-31-378.6K
Q3 '232023-09-30-247.9K
Q2 '232023-06-30-1.3M
Q1 '232023-03-31-579.2K
Q4 '222022-12-3143.4K
Q3 '222022-09-30-170.2K
Q2 '222022-06-30-859.3K
Q1 '222022-03-313K
Q4 '212021-12-31536.7K
Q3 '212021-09-30-672.5K

Cost of Revenue Quarterly

PeriodEndingCost of Revenue
Q2 '262026-06-30614.8K
Q1 '262026-03-31622K
Q4 '252025-12-31736.7K
Q3 '252025-09-30470.7K
Q2 '252025-06-30375.8K
Q1 '252025-03-31506.3K
Q4 '242024-12-31356.8K
Q3 '242024-09-30142.5K
Q2 '242024-06-30422.3K
Q1 '242024-03-31280.4K
Q4 '232023-12-31103.2K
Q3 '232023-09-30120.3K
Q2 '232023-06-30303.4K
Q1 '232023-03-31337.1K
Q4 '222022-12-31477.2K
Q3 '222022-09-3068.6K
Q2 '222022-06-30195.6K
Q1 '222022-03-31226.9K
Q4 '212021-12-31409.5K
Q3 '212021-09-3072.2K

Operating Cash Flow Quarterly

PeriodEndingOperating Cash Flow
Q2 '262026-06-30306K
Q1 '262026-03-31106K
Q3 '252025-09-30-279.9K
Q2 '252025-06-3017.2K
Q1 '252025-03-3160K
Q4 '242024-12-3141.9K
Q3 '242024-09-3052.3K
Q2 '242024-06-30169.1K
Q1 '242024-03-3118.7K
Q4 '232023-12-3155.6K
Q3 '232023-09-30-67.9K
Q2 '232023-06-30-60.6K
Q1 '232023-03-31-342.9K
Q4 '222022-12-31-147K
Q3 '222022-09-30-86.3K
Q2 '222022-06-30-48.9K
Q1 '222022-03-31-108.4K
Q4 '212021-12-3140.9K
Q3 '212021-09-30-273.3K
Q2 '212021-06-30-33.6K

Free Cash Flow Quarterly

Operating cash flow minus capital expenditure.

PeriodEndingFree Cash Flow
Q2 '242024-06-30169.1K
Q1 '242024-03-3118.7K
Q4 '232023-12-3155.6K
Q3 '232023-09-30-67.9K
Q2 '232023-06-30-60.6K
Q1 '232023-03-31-342.9K
Q4 '222022-12-31-147K
Q3 '222022-09-30-86.3K
Q2 '222022-06-30-48.9K
Q1 '222022-03-31-116.4K
Q4 '212021-12-3140.9K
Q3 '212021-09-30-273.3K
Q2 '212021-06-30-33.6K
Q1 '212021-03-31-635.3K
Q4 '192019-12-311.2M
Q3 '192019-09-30-789K
Q2 '192019-06-300
Q1 '192019-03-31-2.2M

EPS TTM

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.

PeriodEndingEPS
Q3 '212021-09-300.02
Q2 '212021-06-300.03
Q1 '212021-03-310.01
Q4 '202020-12-31-0.01
Q3 '202020-09-30-0.03
Q2 '202020-06-30-0.05
Q1 '202020-03-31-0.03
Q4 '192019-12-310.01
Q3 '192019-09-30-0.47
Q2 '192019-06-30-0.86
Q1 '192019-03-31-1.07
Q4 '182018-12-31-1.09
Q3 '182018-09-30-3.39
Q2 '182018-06-30-14.62
Q1 '182018-03-31-15.79
Q4 '172017-12-31-15.82
Q3 '172017-09-30-13.16
Q2 '172017-06-30-1.59
Q1 '172017-03-31-0.22
Q4 '162016-12-31-0.21